
Management Change30 Jul 2026, 06:30 pm
Norris Medicines Appoints Iqubal Ismail Patel as CFO & KMP
AI Summary
Norris Medicines Ltd announced the appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the company. The decision was approved by the Board of Directors in a meeting held on July 30, 2026, following recommendations from the Audit Committee and the Nomination and Remuneration Committee. Mr. Patel has over 11 years of experience with the company in finance, accounts, taxation, budgeting, financial planning, and corporate management. He is not related to any existing Directors or KMPs. His appointment is effective from July 30, 2026, with terms and remuneration to be mutually agreed upon.
Key Highlights
- Iqubal Ismail Patel appointed as CFO and KMP.
- Appointment effective July 30, 2026.
- Patel has 11+ years of experience in finance and management.
- He is not related to any company directors or KMPs.
- Board approved appointment based on committee recommendations.
Price Impact
More from NORRIS